Lowering Interleukin-12 Activity Improves Myocardial and Vascular Function Compared With Tumor Necrosis Factor-a Antagonism or Cyclosporine in Psoriasis

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Circulation Cardiovascular Imaging

• Publication date

  2017-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/CIRCIMAGING.117.006283PMID 28899951
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Skeletal Muscle Alterations Are Exacerbated in Heart Failure With Reduced Compared With Preserved Ejection Fraction: Mediated by Circulating Cytokines?

  2016cited by this paper
• Deficiency of IL-12p35 improves cardiac repair after myocardial infarction by promoting angiogenesis.

  2016cited by this paper
• Regulatory T cells in cardiovascular diseases

  2016cited by this paper
• Similarities in coronary function and myocardial deformation between psoriasis and coronary artery disease: the role of oxidative stress and inflammation.

  2015cited by this paper
• Association of impaired left ventricular twisting‐untwisting with vascular dysfunction, neurohumoral activation and impaired exercise capacity in hypertensive heart disease

  2015cited by this paper
• Tumor necrosis factor-alpha antagonism with etanercept improves endothelial progenitor cell counts in patients with psoriasis: etanercept, vascular function and endothelial progenitor cells in psoriasis.

  2015cited by this paper
• Increased Benefit of Interleukin-1 Inhibition on Vascular Function, Myocardial Deformation, and Twisting in Patients With Coronary Artery Disease and Coexisting Rheumatoid Arthritis

  2014cited by this paper
• Interleukin 17 Drives Vascular Inflammation, Endothelial Dysfunction, and Arterial Hypertension in Psoriasis-Like Skin Disease

  2014cited by this paper
• Remodeling of the Mononuclear Phagocyte Network Underlies Chronic Inflammation and Disease Progression in Heart Failure: Critical Importance of the Cardiosplenic Axis

  2014cited by this paper
• Innate immune response after acute myocardial infarction and pharmacomodulatory action of tacrolimus in reducing infarct size and preserving myocardial integrity

  2013cited by this paper
• Interleukin-12 is associated with arterial stiffness in healthy individuals.

  2013cited by this paper
• Infliximab restores the balance between pro‐ and anti‐apoptotic proteins in regressing psoriatic lesions

  2012cited by this paper
• Treatment With Interleukin-12/23p40 Antibody Attenuates Acute Cardiac Allograft Rejection

  2011cited by this paper
• Surfactants, skin cleansing protagonists

  2010cited by this paper
• From bench to bedside – translational research in psoriasis

  2010cited by this paper
• Comparing biological therapies in psoriasis: implications for clinical practice

  2010cited by this paper
• Survival and Cardiac Remodeling After Myocardial Infarction Are Critically Dependent on the Host Innate Immune Interleukin-1 Receptor–Associated Kinase-4 Signaling: A Regulator of Bone Marrow–Derived Dendritic Cells

  2009cited by this paper
• Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1).

  2008cited by this paper
• Vascular calcification and fetuin-A deficiency in chronic kidney disease.

  2007cited by this paper
• Interleukin 12 Induces T-Cell Recruitment Into the Atherosclerotic Plaque

  2006cited by this paper
• T Cell Recognition and Killing of Vascular Smooth Muscle Cells in Acute Coronary Syndrome

  2006cited by this paper
• Increased productivity of tumor necrosis factor-alpha in helper T cells in patients with systolic heart failure.

  2006cited by this paper
• Risk of myocardial infarction in patients with psoriasis.

  2006cited by this paper
• Prevalence and treatment of psoriasis in the United Kingdom: a population-based study.

  2005cited by this paper
• Myocardial Ischemia Induces Interleukin-6 and Tissue Factor Production in Patients With Coronary Artery Disease: A Dobutamine Stress Echocardiography Study

  2005cited by this paper
• Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risks

  2005cited by this paper
• Blockade of Interleukin-12 Function by Protein Vaccination Attenuates Atherosclerosis

  2005cited by this paper
• Central aortic pressure augmentation in stable renal transplant recipients.

  2002cited by this paper
• Changes in serum interleukin-8 and interleukin-12 levels in patients with ischemic heart disease in a Chinese population.

  2001cited by this paper

• Cardiovascular Outcomes Associated With Biologic Therapy in Inflammatory Dermatologic Diseases: A Systematic Review

  2026cites this paper
• Assessment of Subclinical Atherosclerosis in Patients with Psoriasis Using Echocardiographic Coronary Flow Reserve Parameters: A Systematic Review and Meta-Analysis.

  2025cites this paper
• My Approach to HFpEF Considering Ventricular-Arterial Coupling and Ventricular Interdependence

  2025cites this paper
• Unbiased assessment of 2-arachidonoylglycerol in cardiovascular inflammation

  2025cites this paper
• CAD at the Intersection of Cardiology and Rheumatology: Focus on Cardiovascular Imaging

  2025cites this paper
• Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

  2025cites this paper
• Cardiovascular and Kidney Outcomes After Systemic Treatment for Plaque Psoriasis: A Systematic Review and Network Meta-analysis

  2025cites this paper
• Cardiovascular disease risk in patients with psoriasis receiving biologics targeting TNF-α, IL-12/23, IL-17, and IL-23: A population-based retrospective cohort study

  2025cites this paper
• Como Eu Faço a Avaliação da ICFEp Considerando o Acoplamento Ventrículo-Arterial e a Interdependência Ventricular

  2025cites this paper
• Risk of major adverse cardiovascular events and all-cause mortality among patients with psoriatic disease treated with tumor necrosis factor-α and interleukin-12/23 inhibitors: a nationwide population-based cohort study in Korea

  2024cites this paper
• Does Systemic Anti-Psoriatic Treatment Impact the Risk of Cardiovascular Disease? A Review Over Cardiovascular Imaging Studies

  2024cites this paper
• The role of coronary microcirculation in heart failure with preserved ejection fraction: An unceasing odyssey

  2024cites this paper
• Cardiovascular Comorbidities and Inflammatory Bowel Disease: Causes and Consequences.

  2024cites this paper
• Cardiovascular Disease from Pathophysiology to Risk Estimation: Is Inflammation Estimated through Perivascular Attenuation on Computed Tomography the Key?

  2024cites this paper
• Mechanisms of Vascular Inflammation and Potential Therapeutic Targets: A Position Paper From the ESH Working Group on Small Arteries

  2024cites this paper
• Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

  2023cites this paper
• The importance of microvascular inflammation in ageing and age-related diseases: a position paper from the ESH working group on small arteries, section of microvascular inflammation

  2023cites this paper
• Additive prognostic value of longitudinal myocardial deformation to SCORE2 in psoriasis

  2023cites this paper
• Plasma levels of neurology-related proteins are associated with cognitive performance in an older population with overweight/obesity and metabolic syndrome

  2023cites this paper
• Evidence for Biologic Drug Modifying Anti-Rheumatoid Drugs and Association with Cardiovascular Disease Risk Mitigation in Inflammatory Arthritis.

  2023cites this paper
• Cardiovascular disease in spondyloarthritis: a narrative review of risk factors and the effect of treatments

  2023cites this paper
• Predictive Performances of Blood-Count-Derived Inflammatory Markers for Liver Fibrosis Severity in Psoriasis Vulgaris

  2023cites this paper
• A comprehensive overview of psoriatic research over the past 20 years: machine learning-based bibliometric analysis

  2023cites this paper
• Coronary Microvascular Dysfunction in Asymptomatic Patients with Severe Psoriasis.

  2023cites this paper
• Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

  2022cites this paper
• Ustekinumab-Induced Fatal Acute Heart Failure in a Young Female: A Case Report

  2022cites this paper
• Biomakers in Chronic Chagas Cardiomyopathy

  2022influential citation
• Biomarkers of inflammation and left ventricular remodelling in psoriasis patients treated with infliximab

  2022cites this paper
• Real-World Effects of Biologics on Renal Function in Psoriatic Patients: A Retrospective Study

  2022cites this paper
• Reducing cardiovascular burden in psoriasis patients by using specific therapies – How close are we?

  2022cites this paper
• Future applications of strain imaging

  2022cites this paper
• Prediction and verification of the effect of psoriasis on coronary heart disease based on artificial neural network

  2022cites this paper
• Psoriasis between Autoimmunity and Oxidative Stress: Changes Induced by Different Therapeutic Approaches

  2022cites this paper
• Oxidative Stress and Antioxidant Therapy in Cardiovascular Diseases—Clinical Challenge

  2022cites this paper
• Cardiometabolic Comorbidities in Patients With Psoriasis: Focusing on Risk, Biological Therapy, and Pathogenesis

  2021cites this paper
• Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

  2021cites this paper
• Psoriatic arthritis and the association with cardiometabolic disease: a narrative review

  2021cites this paper
• New Frontiers in Psoriatic Disease Research, Part II: Comorbidities and Targeted Therapies.

  2021cites this paper
• Aortic Stiffness, Inflammation, and Incidence of Cardiovascular Events in Elderly Participants From the General Population

  2021cites this paper
• Human coronary inflammation by computed tomography: Relationship with coronary microvascular dysfunction.

  2021cites this paper
• Effects of Anti-Inflammatory Treatment and Surgical Intervention on Endothelial Glycocalyx, Peripheral and Coronary Microcirculatory Function and Myocardial Deformation in Inflammatory Bowel Disease Patients: A Two-Arms Two-Stage Clinical Trial

  2021cites this paper
• Psoriasis and Cardiovascular Disease: Novel Mechanisms and Evolving Therapeutics

  2021cites this paper
• Management of inflammation in cardiovascular diseases.

  2021cites this paper
• Inflammation in Human Heart Failure: Major Mediators and Therapeutic Targets

  2021cites this paper
• Psoriasis and Atherosclerosis—Skin, Joints, and Cardiovascular Story of Two Plaques in Relation to the Treatment with Biologics

  2021cites this paper
• Multiparametric analysis of coronary flow in psoriasis using a coronary flow reserve companion

  2021cites this paper
• Endothelial glycocalyx and microvascular perfusion are associated with carotid intima-media thickness and impaired myocardial deformation in psoriatic disease

  2021cites this paper
• Inflammation in Coronary Microvascular Dysfunction

  2021cites this paper
• Novel anti‐inflammatory therapies to reduce cardiovascular burden of psoriasis

  2020cites this paper
• Psoriasis: a personalized approach to therapy. The preferred choice of systemic agents considering comorbid pathologies

  2020cites this paper
• SARS-CoV-2 Infection and Cardioncology: From Cardiometabolic Risk Factors to Outcomes in Cancer Patients

  2020cites this paper
• Translational drug discovery and development with the use of tissue‐relevant biomarkers: Towards more physiological relevance and better prediction of clinical efficacy

  2020cites this paper
• Echocardiography in Autoimmune Rheumatic Diseases for Diagnosis and Prognosis of Cardiovascular Complications

  2020cites this paper
• Vascular consequences of inflammation: a position statement from the ESH Working Group on Vascular Structure and Function and the ARTERY Society.

  2020cites this paper
• Investigating the link between psoriasis and cardiovascular disease: current evidence, therapeutic implications and perspectives.

  2020cites this paper
• Aortic Stiffening Is an Extraintestinal Manifestation of Inflammatory Bowel Disease: Review of the Literature and Expert Panel Statement

  2020cites this paper
• Inflammation in Heart Failure: JACC State-of-the-Art Review.

  2020cites this paper
• Coronary Flow Velocity Reserve Reduction Is Associated with Cardiovascular, Cancer, and Noncancer, Noncardiovascular Mortality.

  2020cites this paper
• Do anti TNF-α biologics affect sub-clinical measures of atherosclerosis and arteriosclerosis? A systematic review.

  2020cites this paper
• Chronic inflammatory diseases, myocardial function and cardioprotection

  2020cites this paper
• Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

  2020cites this paper
• Systemic Psoriasis Therapies and Comorbid Disease in Patients with Psoriasis: A Review of Potential Risks and Benefits.

  2019cites this paper
• Chronic inflammation, cardiometabolic diseases and effects of treatment: Psoriasis as a human model.

  2019cites this paper
• Association between genetic polymorphisms of glutathione S-transferase M1/T1 and psoriasis in a population from the area of the strict of messina (Southern Italy)

  2019cites this paper
• Imaging Risk in Multisystem Inflammatory Diseases.

  2019cites this paper
• Assessing the relative efficacy of interleukin-17 and interleukin-23 targeted treatments for moderate-to-severe plaque psoriasis: A systematic review and network meta-analysis of PASI response

  2019cites this paper
• Effects of Interleukin 17A Inhibition on Myocardial Deformation and Vascular Function in Psoriasis.

  2019cites this paper
• Anti‐inflammatory agents in peripheral arterial disease

  2018cites this paper
• The Association of Helicobacter pylori Infection with Endothelial Dysfunction in Pediatric Patients

  2018cites this paper
• Targeting the IL-23/IL-17 Pathway in Psoriasis: the Search for the Good, the Bad and the Ugly

  2018cites this paper
• Established agents against atherosclerotic disease with anti-inflammatory properties

  2017cites this paper
• Interleukin Antagonists: Have We Found the Right One to Block? Are Cardiovascular Effects of Biologic Therapies Similar?

  2017cites this paper
• Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment

  2017cites this paper
• Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

  2017cites this paper